"10.1371_journal.pone.0043803","none","2012-08-27T00:00:00Z","Todd Hulgan; Gregory K Robbins; Spyros A Kalams; David C Samuels; Benjamin Grady; Robert Shafer; Deborah G Murdock; Doug Selph; David W Haas; Richard B Pollard; AIDS Clinical Trials Group","Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America; Massachusetts General Hospital/Harvard University, Boston, Massachusetts, United States of America; Stanford University Medical Center, Stanford, California, United States of America; University of California Davis, Sacramento, California, United States of America","Conceived and designed the experiments: TH GKR SAK DCS RS DGM DWH RBP. Performed the experiments: GKR DCS BG RS DS RBP. Analyzed the data: TH DCS BG DS. Contributed reagents/materials/analysis tools: TH DCS BG DS. Wrote the paper: TH GKR DCS RBP. Critically revised the manuscript: TH GKR SAK DCS BG RS DGM DS DWH RBP. Approved the final version to be published: TH GKR SAK DCS BG RS DGM DS DWH RBP.","The authors have read the journal’s policy and have the following conflicts: TH has received research support from Merck. GKR has received research support from Gilead Sciences, Schering-Plough. DWH has received research grants from Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, and Merck, and has served as a consultant for Boehringer-Ingelheim. AIDS Clinical Trials Group (ACTG) Study 384 was also supported in part by Agouron/Pfizer, Bristol Myers Squibb, and GlaxoSmithKline. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2012","08","Todd Hulgan","TH",11,TRUE,8,6,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
